ClinicalTrials.Veeva

Menu

HOme USability Evaluation (HOUSE)

E

Entia

Status

Not yet enrolling

Conditions

Cancer

Treatments

Device: Entia Liberty

Study type

Observational

Funder types

Industry

Identifiers

NCT06134245
IRAS ID: 336920

Details and patient eligibility

About

To validate the usability and safety of the Liberty Analyser.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Undergoing systemic anti-cancer therapy (SACT)
  • Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, 2 at enrolment
  • Adequate English language skills (not requiring a translator) to participate in participant training and use the Entia Liberty analyser
  • Patients capable of providing written informed consent

Exclusion criteria

  • History or current diagnosis of haematological malignancy
  • Patients with eyesight or hearing limitations or other disabilities that preclude the use of the Entia Liberty analyser or participation in training
  • Inadequate use and understanding of the English language, requiring a translator

Trial contacts and locations

0

Loading...

Central trial contact

Madeline Lok; Hannah Rawlinson-Smith

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems